Holen Sie sich die Stockscreener-App
2.34
0.00%
0.00
Schlusskurs vom Vortag:
$2.34
Offen:
$2.34
24-Stunden-Volumen:
14,221
Relative Volume:
0.55
Marktkapitalisierung:
$13.82M
Einnahmen:
$22.10M
Nettoeinkommen (Verlust:
$-4.15M
KGV:
-6.8602
EPS:
-0.3411
Netto-Cashflow:
$-1.64M
1W Leistung:
+0.00%
1M Leistung:
+0.43%
6M Leistung:
-8.95%
1J Leistung:
+1.74%
1-Tages-Spanne:
$2.335
$2.345
1-Wochen-Bereich:
$2.325
$2.35
52-Wochen-Spanne:
$1.63
$3.93
Psychemedics Corp Stock (PMD) Company Profile
Firmenname
Psychemedics Corp
Sektor
Branche
Telefon
978-206-8220
Adresse
125 NAGOG PARK, ACTON, MA
Vergleichen Sie PMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PMD
Psychemedics Corp
|
2.34 | 13.82M | 22.10M | -4.15M | -1.64M | -0.3411 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Psychemedics Corp Aktie (PMD) Neueste Nachrichten
Psychemedics shareholders approve reverse and forward stock splits - Investing.com
Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders - Yahoo Finance
Psychemedics Third Quarter 2024 Earnings: US$0.091 loss per share (vs US$0.36 loss in 3Q 2023) - Yahoo Finance
Psychemedics: Q3 Earnings Snapshot - The Washington Post
Psychemedics Q3 Loss Narrows Despite 9% Revenue Drop; Shares Show Mixed Results | PMD Stock News - StockTitan
Drug Screening Market Analysis of The Key Players, Growth Status, Business Strategies and Scope with Outlook - The Globe and Mail
Form DEF 14A PSYCHEMEDICS CORP For: Nov 25 - StreetInsider.com
PMD (Psychemedics) Shares Outstanding (EOP) : 5.82 Mil (As of Jun. 2024) - GuruFocus.com
U.S. Employer and Workplace Drug Testing Market Report 2024, Featuring First Advantage, Labcorp, Dragerwerk, Quest Diagnostics, Cordant Health Solutions, HireRight, Omega Laboratories & Psychemedics - Yahoo Finance
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing - Yahoo Finance
Survey: Mental health professionals largely open to psychedelic treatments – if legal - Green Market Report
474% return in 1 year: PC Jeweller shares hit fresh 52-week high as board to consider stock split - MSN
PC Jeweller's first share split announced: 180 percent multibagger gain in just 3 months - India.com
PC Jeweller Soars 452%! Big News Ahead as Company Plans First-Ever Stock Split on September 30 - Share Price India News
At 52-week high! Multibagger stock PC Jeweller to declare stock split after 452% surge in one year - MSN
This jewellery stock hits 52-week high as board to consider stock split; check details - Upstox
PC Jewellers shares rise 4% on considering stock split in upcoming board meeting - The Economic Times
PC Jeweller shares hit 52-week high ahead of board meeting to consider stock split - Business Upturn
PC Jeweller hits 52-wk high as board to consider stock split on Sept 30 - Business Standard
At 52-week high! Multibagger stock PC Jeweller to declare stock split after 452% surge in one year | Stock Market News - Mint
PC Jeweller shares in news today as board to consider stock split - Business Today
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $89,600.00 in Stock - Defense World
Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neur - GuruFocus.com
Psyence Group offloads PsyLabs stake to spinoff - Green Market Report
PC Jeweller to consider stock split on September 30 - CNBCTV18
Epineuron Announces Health Canada Approval of the PeriPulse™ System for Nerve Regeneration - Business Wire
Popular Foundations Shares Underperform At Market Debut - Knn India
Popular Foundations shares make tepid debut on BSE SME, list flat at ₹37 | Stock Market News - Mint
BSE SME Popular Foundation slips on debut - Business Standard
Popular Foundations shares list at IPO price on BSE SME platform - The Economic Times
Popular Foundations makes tepid debut, shares list flat at ₹37 apiece on BSE SME platform - Upstox
Popular Foundations share price hits lower circuit post listing, falls 5% from IPO price - Moneycontrol
Recent Insider Activity Could Benefit Personalis Inc (PSNL) - Knox Daily
Small Cap Stocks: Plexus, Parkmead, Proton Motor - The Armchair Trader
LIC-backed multibagger stock under Rs 150 is locked in the upper circuit on September 23; Stock gained 475 per cent from its 52-week low - Dalal Street Investment Journal
Psp Projects shares surge 3% after receiving orders worth Rs 554.92 crore - Business Upturn
2 ASX shares I can’t ignore: PME and SOL - Rask Media
Should PME shares be on your watchlist? - Rask Media
Insider Buying: Tempus AI, Inc., Personalis Inc [PSNL] 10% Owner invested 3,500,000 shares - Knox Daily
Psychemedics Corporation Launches New Ketamine Hair Testing Service - Yahoo Finance
PMD Stock Earnings: Psychemedics Reported Results for Q2 2024 - MSN
Psychemedics: Q2 Earnings Snapshot - San Antonio Express-News
Psychemedics (PMD) Strategic Move Spurs Share Price Increase - Stocks Telegraph
Psychemedics to delist from Nasdaq after reverse stock split - Investing.com
Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock - Yahoo Finance
Psychemedics stock plunges to 52-week low at $1.66 - Investing.com
Psychemedics stock hits 52-week low at $2.05 amid challenges - Investing.com India
Psychemedics Corp (NASDAQ:PMD)Research - Intelligent Investor
After Moving HQ to Dallas, Psychemedics Releases Report on Drug Trends in the U.S. Workplace - dallasinnovates.com
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing - Yahoo Finance
One Psychemedics Corporation (NASDAQ:PMD) insider upped their stake by 13% in the previous year - Yahoo New Zealand News
Finanzdaten der Psychemedics Corp-Aktie (PMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):